Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
Frontiers in Pharmacology|September 9, 2020
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue SarcomasMatteo Cassandri, Rossella Fioravanti, Silvia Pomella, et al.
Plos Neglected Tropical Diseases|September 25, 2015
Targeting Lysine Deacetylases (KDACs) in ParasitesQi Wang, Bruce A Rosa, Bakela Nare, et al.
Journal of Medicinal Chemistry|April 29, 2005
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamidesAntonello Mai, Silvio Massa, Riccardo Pezzi, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2025
An improved multiplex RT-quantitative PCR assay can reveal sex-specific activity of transmission-blocking drugs on ex vivo gametocytes from Plasmodium falciparum asymptomatic infectionsMariagrazia Ciardo, Noëlie B Henry, Issiaka Soulama, et al.
Chemmedchem|April 1, 2025
Development of C646-Based Proteolysis Targeting Chimeras Degraders of the Lysine Acetyltransferases CBP and p300Francesco Fiorentino, Filippo Spriano, Daniela Tomaselli, et al.
Cancer Gene Therapy|September 18, 2022
Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cellsMohammad Salik Zeya Ansari, Venturina Stagni, Angela Iuzzolino, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
α,γ-Diketocarboxylic Acids and Their Esters Act as Carbonic Anhydrase IX and XII Selective InhibitorsAlessio Nocentini, Alessia Lucidi, Francesca Perut, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatmentC Colussi, C Banfi, M Brioschi, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Synthesis and structure--activity relationship of new cytotoxic agents targeting human glutathione-S-transferasesDante Rotili, Anastasia De Luca, Domenico Tarantino, et al.
International Journal of Oncology|February 15, 2011
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cellsMaria Meli, Manlio Tolomeo, Mario Grifantini, et al.
Pageof 20